Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date
Valeant Hits Another Bump
Jul 22 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Higher, FDA Panel Backs Psoriasis Drug
Jul 19 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment
Jul 22 / TheStreet.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
Valeant Drug Approval Hampered by FDA Facility Inspection
Jul 22 / TheStreet.com - Paid Partner Content
Valeant Partnership With Walgreens in Trouble: Andrew Left
Jul 18 / TheStreet.com - Paid Partner Content
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant-Walgreens Partnership Destined to Flop, Andrew Left Says
Jul 18 / TheStreet.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
3 Stocks Driving The Health Care Sector Higher
Jul 18 / TheStreet.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Higher Ahead of Anticipated FDA Approval
Jul 18 / TheStreet.com - Paid Partner Content
Valeant's Drug Approvals May Save the Day
Jul 20 / TheStreet.com - Paid Partner Content
Learn from Bill Ackman's Mistakes
Jul 18 / GuruFocus News - Paid Partner Content
Jim Cramer -- Valeant Needs These New Drug Approvals
Jul 20 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals' Second-Largest Shareholder Just Abandoned Ship -- Should You...
Jul 15 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug
Jul 20 / TheStreet.com - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Ionis Pharmaceuticals, In...
Jul 15 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
Why Cree, Harsco, and Valeant Pharmaceuticals Jumped Today
Jul 14 / MotleyFool.com - Paid Partner Content
Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles
Jul 20 / TheStreet.com - Paid Partner Content
Company News for July 14, 2016
Jul 14 / Zacks.com - Paid Partner Content
Here's the Most Overrated Investing Metric You'll Ever See
Jul 20 / MotleyFool.com - Paid Partner Content
Casella Waste, Valeant Pharma, Yum Brands and CSX highlighted as Zacks Bull and Bear ...
Jul 14 / Zacks.com - Paid Partner Content
Morning Movers: MS, VRX, MSFT, ISRG
Jul 20 / TheStreet.com - Paid Partner Content
Bear of the Day: Valeant Pharma (VRX)
Jul 14 / Zacks.com - Paid Partner Content
Futures Point Downward for U.S. Markets as Asia Opens Lower
Jul 19 / TheStreet.com - Paid Partner Content
3 Prime Reasons Why Valeant Pharmaceuticals Intl. Inc. Plunged 29% in June
Jul 13 / MotleyFool.com - Paid Partner Content
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's Post-Market Leade...
Jul 19 / TheStreet.com - Paid Partner Content
Billionaires Are Piling Into These 3 Stocks
Jul 12 / MotleyFool.com - Paid Partner Content
New Valeant (VRX) Drug Gains Approval From FDA Panel
Jul 19 / TheStreet.com - Paid Partner Content
The Most Important Thing Walgreens Said About Valeant Pharmaceuticals
Jul 09 / MotleyFool.com - Paid Partner Content